vs
Side-by-side financial comparison of HireQuest, Inc. (HQI) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $7.0M, roughly 1.8× HireQuest, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 22.8%, a 227.9% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -13.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -8.6%).
Quest, also known as Quest - Hire a Hero, is a Singapore-based technology company founded in 2021 that operates an AI-powered on-demand services marketplace. The platform connects users with verified workers, known as “Heroes” to complete a wide range of tasks.
HQI vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $12.6M |
| Net Profit | $1.6M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 18.6% | — |
| Net Margin | 22.8% | 250.7% |
| Revenue YoY | -13.0% | 24080.8% |
| Net Profit YoY | -27.8% | 250.9% |
| EPS (diluted) | $0.11 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $12.6M | ||
| Q3 25 | $8.5M | $0 | ||
| Q2 25 | $7.6M | $0 | ||
| Q1 25 | $7.5M | $12.0K | ||
| Q4 24 | $8.1M | $52.0K | ||
| Q3 24 | $9.4M | $65.0K | ||
| Q2 24 | $8.7M | $114.0K | ||
| Q1 24 | $8.4M | $140.0K |
| Q4 25 | $1.6M | $31.5M | ||
| Q3 25 | $2.3M | $-7.4M | ||
| Q2 25 | $1.1M | $-1.7M | ||
| Q1 25 | $1.4M | $-13.9M | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $-2.2M | $-17.1M | ||
| Q2 24 | $2.0M | $-17.9M | ||
| Q1 24 | $1.6M | $-12.7M |
| Q4 25 | 18.6% | — | ||
| Q3 25 | 28.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 19.8% | -122758.3% | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | -28.6% | -28604.6% | ||
| Q2 24 | 31.0% | -16720.2% | ||
| Q1 24 | 25.0% | -9987.1% |
| Q4 25 | 22.8% | 250.7% | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 18.2% | -115550.0% | ||
| Q4 24 | 27.5% | — | ||
| Q3 24 | -23.4% | -26380.0% | ||
| Q2 24 | 23.5% | -15668.4% | ||
| Q1 24 | 19.2% | -9049.3% |
| Q4 25 | $0.11 | $0.56 | ||
| Q3 25 | $0.16 | $-0.13 | ||
| Q2 25 | $0.08 | $-0.03 | ||
| Q1 25 | $0.10 | $-0.25 | ||
| Q4 24 | $0.15 | — | ||
| Q3 24 | $-0.16 | $-0.32 | ||
| Q2 24 | $0.15 | $-0.33 | ||
| Q1 24 | $0.12 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $68.3M | $59.0M |
| Total Assets | $88.2M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $68.3M | $59.0M | ||
| Q3 25 | $67.8M | $26.5M | ||
| Q2 25 | $66.0M | $32.8M | ||
| Q1 25 | $65.6M | $33.8M | ||
| Q4 24 | $64.8M | $46.1M | ||
| Q3 24 | $62.9M | $65.5M | ||
| Q2 24 | $65.4M | $80.5M | ||
| Q1 24 | $63.9M | $96.2M |
| Q4 25 | $88.2M | $68.9M | ||
| Q3 25 | $94.9M | $54.2M | ||
| Q2 25 | $94.3M | $62.1M | ||
| Q1 25 | $93.7M | $77.7M | ||
| Q4 24 | $94.0M | $110.5M | ||
| Q3 24 | $102.7M | $135.2M | ||
| Q2 24 | $107.6M | $149.9M | ||
| Q1 24 | $105.9M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 4.12× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.6M | $-8.4M | ||
| Q3 25 | $1.0M | $17.4M | ||
| Q2 25 | $2.6M | $-17.7M | ||
| Q1 25 | $1.9M | $-4.0M | ||
| Q4 24 | $8.7M | $-23.4M | ||
| Q3 24 | $4.2M | $12.8M | ||
| Q2 24 | $188.0K | $-18.7M | ||
| Q1 24 | $-967.0K | $5.9M |
| Q4 25 | 4.12× | -0.26× | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 3.90× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | -0.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
